228 related articles for article (PubMed ID: 29799646)
1. Primary role of barrier dysfunction in the pathogenesis of atopic dermatitis.
Elias PM
Exp Dermatol; 2018 Aug; 27(8):847-851. PubMed ID: 29799646
[TBL] [Abstract][Full Text] [Related]
2. Barrier repair therapy in atopic dermatitis: an overview.
Hon KL; Leung AK; Barankin B
Am J Clin Dermatol; 2013 Oct; 14(5):389-99. PubMed ID: 23757122
[TBL] [Abstract][Full Text] [Related]
3. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
Kubo A; Nagao K; Amagai M
J Clin Invest; 2012 Feb; 122(2):440-7. PubMed ID: 22293182
[TBL] [Abstract][Full Text] [Related]
4. Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients.
van Smeden J; Bouwstra JA
Curr Probl Dermatol; 2016; 49():8-26. PubMed ID: 26844894
[TBL] [Abstract][Full Text] [Related]
5. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
[TBL] [Abstract][Full Text] [Related]
6. Role of the epidermal barrier in atopic dermatitis.
Proksch E; Fölster-Holst R; Bräutigam M; Sepehrmanesh M; Pfeiffer S; Jensen JM
J Dtsch Dermatol Ges; 2009 Oct; 7(10):899-910. PubMed ID: 19682176
[TBL] [Abstract][Full Text] [Related]
7. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis.
Wolf R; Wolf D
Clin Dermatol; 2012; 30(3):329-34. PubMed ID: 22507048
[TBL] [Abstract][Full Text] [Related]
8. Eczema and ceramides: an update.
Jungersted JM; Agner T
Contact Dermatitis; 2013 Aug; 69(2):65-71. PubMed ID: 23869725
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.
Elias PM; Wakefield JS
J Allergy Clin Immunol; 2014 Oct; 134(4):781-791.e1. PubMed ID: 25131691
[TBL] [Abstract][Full Text] [Related]
10. Reconstructed human epidermis for in vitro studies on atopic dermatitis: A review.
Huet F; Severino-Freire M; Chéret J; Gouin O; Praneuf J; Pierre O; Misery L; Le Gall-Ianotto C
J Dermatol Sci; 2018 Mar; 89(3):213-218. PubMed ID: 29248403
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function mutations within the filaggrin gene and atopic dermatitis.
Kawasaki H; Kubo A; Sasaki T; Amagai M
Curr Probl Dermatol; 2011; 41():35-46. PubMed ID: 21576945
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.
Elias PM; Wakefield JS
Clin Rev Allergy Immunol; 2011 Dec; 41(3):282-95. PubMed ID: 21174234
[TBL] [Abstract][Full Text] [Related]
13. Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis.
Elias PM; Wakefield JS; Man MQ
Skin Pharmacol Physiol; 2019; 32(1):1-7. PubMed ID: 30336483
[TBL] [Abstract][Full Text] [Related]
14. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis.
Thyssen JP; Kezic S
J Allergy Clin Immunol; 2014 Oct; 134(4):792-9. PubMed ID: 25065719
[TBL] [Abstract][Full Text] [Related]
15. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.
Jungersted JM; Scheer H; Mempel M; Baurecht H; Cifuentes L; Høgh JK; Hellgren LI; Jemec GB; Agner T; Weidinger S
Allergy; 2010 Jul; 65(7):911-8. PubMed ID: 20132155
[TBL] [Abstract][Full Text] [Related]
16. Optimizing emollient therapy for skin barrier repair in atopic dermatitis.
Elias PM
Ann Allergy Asthma Immunol; 2022 May; 128(5):505-511. PubMed ID: 35065300
[TBL] [Abstract][Full Text] [Related]
17. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling.
Angelova-Fischer I; Mannheimer AC; Hinder A; Ruether A; Franke A; Neubert RH; Fischer TW; Zillikens D
Exp Dermatol; 2011 Apr; 20(4):351-6. PubMed ID: 21410766
[TBL] [Abstract][Full Text] [Related]
18. Skin barrier in atopic dermatitis.
Kezic S; Novak N; Jakasa I; Jungersted JM; Simon M; Brandner JM; Middelkamp-Hup MA; Weidinger S
Front Biosci (Landmark Ed); 2014 Jan; 19(3):542-56. PubMed ID: 24389202
[TBL] [Abstract][Full Text] [Related]
19. Filaggrin mutations and atopy: consequences for future therapeutics.
Heimall J; Spergel JM
Expert Rev Clin Immunol; 2012 Feb; 8(2):189-97. PubMed ID: 22288457
[TBL] [Abstract][Full Text] [Related]
20. Electron diffraction study of lipids in non-lesional stratum corneum of atopic eczema patients.
Janssens M; Mulder AA; van Smeden J; Pilgram GS; Wolterbeek R; Lavrijsen AP; Koning RI; Koster AJ; Bouwstra JA
Biochim Biophys Acta; 2013 Aug; 1828(8):1814-21. PubMed ID: 23583924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]